A carregar...

Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials

BACKGROUND: In Phase 3 studies, teriflunomide reduced relapse rates and disability progression compared with placebo; however, decreases in lymphocyte counts were also observed. OBJECTIVE: To describe the effect of long-term teriflunomide treatment on lymphocyte counts and infection rates among pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mult Scler
Main Authors: Comi, Giancarlo, Miller, Aaron E, Benamor, Myriam, Truffinet, Philippe, Poole, Elizabeth M, Freedman, Mark S
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7412877/
https://ncbi.nlm.nih.gov/pubmed/31172849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458519851981
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!